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Abstract
Chronic inflammation has been associated with the development of multiple
malignancies including neurodegenerative diseases like Parkinson’s and Alzheimer’s Disease
and cancer. Using naturally occurring compounds with anti-inflammatory effects is an attractive
way to prevent diseases associated with inflammation. BG-4 is a novel peptide isolated from
the seeds of bitter melon (Momordica charantia) with potent trypsin inhibitory activity. The
objective of this research is to evaluate the capability of BG-4 to inhibit lipopolysaccharide(LPS)induced inflammation in THP-1 human macrophages. THP-1 human macrophages were pretreated with different concentrations of BG-4 for 8 h and challenged with LPS for 16 h. The antiinflammatory effects were evaluated by measuring the secretion of pro-inflammatory cytokines
IL-1β, IL-6 and TNF-α compared to untreated THP-1 macrophages. The mechanism of action
was explored using the NF-κB signaling pathway. BG-4 pre-treatment of 50 µg/mL reduced
production of IL-6 by 88.4% and TNF-α by 50.7%. BG-4 also decreased the nuclear translocation
of p65 NF-κB subunit as measured by immunofluorescence microscopy and western blot. Our
data indicates the potential of BG-4 to prevent diseases associated with aberrant and
uncontrolled inflammation.

1. Introduction
Momordica charantia, also known as bitter gourd (BG) or bitter melon, is a perennial
plant belonging to the the Cucurbitaceae or cucurbit family. It is cultivated throughout the
world and has traditionally been used in folk medicine. Pre-clinical studies have shown that M.
charantia can be especially effective against type II diabetes. In the indigenous populations of

Asia, South America, and Africa where this treatment is popular, plant-based medicine is the
most cost-effective way to treat diabetes and other related diseases. [1] Recent studies have
also shown the capability of BG to affect different processes in carcinogenesis. An extract from
BG inhibited ovarian cancer tumorigenicity in vitro and in vivo by activating the AMPK signaling
pathway. [2] In addition, two ribosome-inactivating proteins isolated from BG called αmomorcharin and momordica anti human immunodeficiency virus protein arrested cell cycle
and induced apoptosis in lung cancer cells.[3] Recently, a novel peptide from BG with strong
trypsin inhibitory properties was identified and named BG-4. The peptide was isolated from the
seeds of the gourd by a simple 70% aqueous ethanol extraction [4] (Figure 1A). BG-4 caused
the strong trypsin inhibitory activity of the extract as increasing purity of the extract led to
increased trypsin inhibition. In addition, purified BG-4 was at least 8 times more potent in
inhibiting trypsin activity than the purified soybean trypsin inhibitor (Figure 1B). Trypsin
inhibitors have historically been shown to interrupt different stages of carcinogenesis. In
recent studies, ulinistatin, a type of urinary trypsin inhibitor, suppressed proliferation and
motility of gastric cancer cells [5] and reduced resistance of liver cancer cells to
chemotherapeutic agent epirubicin by promoting apoptosis and inhibiting NF-κB signaling. [6]
In addition food derived trypsin inhibitors have shown anticancer activities including BowmanBirk and Kunitz trypsin inhibitors from soybean [7], buckwheat trypsin inhibitor [8], and other
legumes trypsin inhibitors[9]. BG-4 demonstrated the capability of BG-4 to cause cytotoxicity
and promote apoptosis in HT-29 and HCT-116 human colon cancer cells[4].
THP-1 cells have been commonly used as an in vitro model of human monocyte and
macrophages in studies on inflammatory diseases [10]. Sharif et al. [11] showed that THP-1

cells treated with LPS responded with a change in expression of a number of inflammationrelated genes (IL-1β, IL-6, IL-8, IL-10 and TNF-α). In addition, exposure of THP-1 monocytes to
LPS results in activation of the NF-κB transcription factor, which arranges a gene expression
program leading to the activation of inflammation, cell proliferation, differentiation, migration
and cell survival, which are mediated through the release of chemokines and cytokines [11, 12]
These previous studies on the potential beneficial role of trypsin inhibitors in cancer
chemoprevention and therapy and the previous study identifying BG-4 as a peptide to promote
apoptosis in human colon cancer cells serve as the scientific premise to study BG-4 as a means
to inhibit LPS induced inflammation in THP-1 human macrophages.
2. Materials and Methods
2.1 Materials
THP-1 cells were obtained from the American Type Culture Collection (Manasas, VA,
USA). BG-4 was isolated and purified from bitter gourd seeds as previously reported [4]. All
chemicals were purchased from VWR (Radnor, PA, USA), Fisher Scientific (Atlanta, GA, USA), or
Bio-Rad (Hercules, CA, USA) unless stated otherwise.
2.2 Cell Culture
THP-1 cells were differentiated from monocytes to macrophages using phorbol 12myristate 13-acetate (PMA) as the differentiation agent. THP-1 was cultured using Roswell Park
Memorial Institute-1640 media (RPMI 1640) (ATCC) containing 10% fetal bovine serum, 1%
penicillin-streptomycin, 1% sodium pyruvate, and 50 µM beta-mercaptoethanol (to prevent
cross-linking of Fc receptors on the cell by the antibody in serum and therefore avoiding
damaging cell function) and incubated at 37ºC in 5%CO2/95% air. PMA was added at a

concentration of 162 nM to promote differentiation of THP-1 cells into macrophages as
previously described by Furundzija et al [13] with some modifications. Macrophage
differentiation was allowed for 24 h and it was determined by cell morphology and total
adhesion to the plate. After differentiation, THP-1 cells were pre-treated with non-cytotoxic
doses of BG-4 ranging from 6.25 to 50 ppm for 8 hours and the cells were challenged with 1
µg/mL LPS from Escherichia coli O55:B5 for 16 hours. Afterwards the cell spent medium was
collected and analyzed for TNF-α and IL-6 secretion as measures of pro-inflammatory effects of
LPS.
2.3 Whole Cell Lysate Harvesting
To obtain the whole cell lysate, a RIPA lysis buffer-protease inhibitor cocktail mix was
prepared. One hundred µL of lysis buffer was added to each well of a 6-well plate and the plate
was incubated at 4 °C for 5 min. Using a cell scraper, the plates were scraped and the cell
lysates were transferred into pre-chilled 1.5-mL microfuge tubes and vortexed for 5 min in a
cold room. They were then centrifuged at 14,000 x g for 10 min at 4ºC. The supernatant was
collected and the pellet discarded. The protein concentration of the supernatant was
measured using Bradford Assay. To the remaining supernatant, equal volumes of Laemmli
buffer with β-mercaptoethanol were added and boiled for 5 min. Cell lysates were stored at 20 until analysis by Western Blot.
2.4 Separation of Cytosolic and Nuclear Fractions
In a similar fashion to the harvesting of the whole cell lysate, to separate the cytosolic
and nuclear fractions cells were washed with ice-cold PBS 2x. Using a cell scraper, the cells
were then scraped with 500 µL ice-cold PBS and centrifuged for 5 min at 1000 x g at 4ºC. The

supernatant was then discarded. One hundred µL of lysis buffer containing 0.01M DTT and
protease inhibitors was added and the cells were re-suspended by gently pipetting the
suspension. The cells were then incubated on ice for 15 min to allow to swell. After which, 20
µL of 10% Triton X100 was added and vortexed vigorously for 10 seconds. They were then
centrifuged immediately for 1 min at 14,000 x g. The supernatant (cytosolic fraction) was then
discarded. To the pellet, 50 µL of extraction buffer containing 0.01 M DTT and protease
inhibitors was and vortex mixed in a cold room (4ºC) at high speed for 30 min. They were then
centrifuged for 5 min at 21,000 x g at 4 °C. The supernatant (nuclear fraction) was transferred
to a pre-chilled microfuge tube. The protein concentrations were determined using Bradford
Assay. To the remaining fraction, equal volumes of Laemmli buffer with β-mercaptoethanol
were added and boiled for 5 min. All boiled fractions were stored at -20ºC until analysis.
2.4 ELISA
The Human IL-6 and TNF-α MAX™ Deluxe Set from Bio-Legend (San Diego, CA, USA) was
used for ELISA testing. All reconstitutions and preparations were done as indicated on the
instruction sheet from the manufacturer. On Day 1, 100 µL of diluted Capture Antibody
solution were added to each well and the plate was sealed and incubated overnight between
2ºC and 8ºC. On Day 2 the plate (each well) was washed 4 times with wash buffer and 200 µL
1X Assay Diluent A was added to each well to block the plate. It was then sealed and incubated
at room temperature for an hour while on a plate shaker. After washing 4 more times with
wash buffer, 100 µL of either standard dilutions or diluted samples was added to each well.
The plate was sealed and incubated at room temperature for 2 hours with shaking. The plate
was washed 4 more times and 100 µL detection antibody solution was added and the plate was

incubated with shaking for another hour at room temperature. After washing the plate 4X, 100
µL diluted Avidin-HRP solution was added to each well and the plate was sealed and incubated
for 30 min with shaking at room temperature. The plate was then washed 5X with soaking for
30 sec-1 min per wash and 100 µL of substrate solution was added and the plate incubated in
the dark for 20 min. The reaction was stopped by adding 100 µL of 2 M H2SO4 to each well and
the absorbance read at 450 nm on a Cambrex ELX 808 microplate reader (Biotek Instruments,
Winooski VT, USA). The concentration of IL-6 and TNF-α was calculated from the generated
standard curve.
2.5 SDS-PAGE and Western Blot
Frozen samples were thawed at room temperature and vortexed for about 3 seconds. A
1X Tris/glycine SDS buffer was prepared (100 mL 10X Tris/glycine SDS buffer (161-0732, Biorad)
+ 900 mL deionized water). The gel cassette was placed in the electrode assembly and the
frame was clamped. The center was filled with running buffer to ensure no leaks. After placing
the assembly into the electrophoresis tank, the tank was filled with running buffer and the wells
were loaded with 5 µL Precision Plus Protein Dual Color Standard (molecular weight standard)
and samples with pre-determined volume based on equal protein loading were loaded. Protein
separation was run at 200V for 30-35 min. The gels were then pre-equilibrated in ice-cold
blotting buffer and proteins were transferred to PVDF membrane (GE Healthcare Life Sciences,
Pittsburgh PA) at 110 V for 1 h at 4 °C. The blots were blocked with 5% non-fat dry milk for 1 h
at room temperature, washed three times with TBS containing 0.1% Tween 20 (TBST) for 5 min
and incubated with primary antibody overnight at 4 °C at 1:1000 dilution. The blots were
washed with TBST five times for 5 min and incubated with secondary antibody at 1:5000

dilution for 2 h at room temperature. After washing with TBST, the blots were imaged with CDigit Blot scanner (Li-Cor Biosciences, Lincoln, NE) using WesternSure ECL Substrate (Li-Cor
Biosciences, Lincoln, NE). The intensity of bands was quantified using Image Studio Software (LiCor Biosciences, Lincoln, NE, USA).
2.6 Intracellular Reactive Oxygen Species
For fluorescence microscopy, the THP-1 cells were seeded and treated as appropriate
and the cells were then washed with PBS twice. One-mL of 10 µM 2′,7′-dichlorofluorescein
diacetate was added to cover the whole surface of the cells. After incubation at 37 ºC for 30
min in the carbon dioxide incubator, the stain solution was removed and washed with PBS
twice. The cells were overlaid with 50% glycerol and imaged using the Invitrogen EVOS FL auto
cell imaging system (ThermoFisher Scientific, Waltham MA).
For fluorescence spectroscopy cells were seeded the same way and washed with PBS
2X. Cells were dislodged from the plate by adding 200 µL of trypsin-EDTA solution and
incubated at 37 °C for 5 min. After incubation, 800 µL of complete medium with 10% FBS was
added to inactivate trypsin and then centrifuged at 1000 x g for 5 min and the supernatant
discarded. One mL of PBS was added to carefully re-suspend the cells and then centrifuged. Tye
cells were re-suspended in 500 µL of PBS containing 10 µM 2′,7′-dichlorofluorescein diacetate
and incubated at 37ºC for 30 min in the carbon dioxide incubator. After vortex mixing, 200 µL
of the suspension (in duplicate) was plated in a 96-well black plate. Fluorescence intensity was
read at 485 nm/528 nm on a Synergy microplate reader (BioTek, Winooski, VT, USA).

2.7 Immunofluorescence (p-STAT3 and p-65)
Cells were treated per protocol, growth medium removed, and washed with PBS 2x.
Cells were fixed with 500 µL of 4% paraformaldehyde at room temperature for 15 min. After
washing the cells 3x (5 min each time) with PBS, 500 µL of 0.1% Triton X100 was added and
then incubated for 10 min at room temperature. Cells were washed as before and 5% BSA was
added to each well (500 µL) and incubated for 1 hour at room temperature (blocking step).
Cells were washed as before and 200 µL of diluted primary antibody were added to each well
and incubated at 4ºC overnight. Cells were washed as before and 200 µL of diluted secondary
antibody was added and incubate for 2 hours at room temperature in the dark. The cells were
washed and 2 drops of the mounting medium with DAPI was added. The cells cured for 24
hours at room temperature in the dark and were then imaged using a fluorescence microscope.
The primary antibodies were p65 (1-mL 5% BSA, 4-mL PBS and 25 µL p-65 antibody) and c-Jun
(1-mL 5% BSA, 4-mL PBS and 25 µL p-STAT3 antibody. Vortexed prior to use). The secondary
antibody was Alexa-Fluor 488-conjugated anti-rabbit (2-mL 5%BSA, 8-mL PBS and 10 µL goat
antirabbit Alexa-Fluor 488 conjugate).

2.8 Statistical Analysis
Data were analyzed using analysis of variance utilizing the proc GLM procedure of Statistical
Analysis System software version 9.4. Means were separated using Tukey’s posthoc analysis at
P < 0.05.

3. Results and Discussion
3.1 BG-4 Pre-treatment reduced the secretion of pro-inflammatory cytokines
Macrophages respond to LPS by expressing many inflammatory cytokines. The pathway
occurs as follows: LPS binds to LPS-binding protein and is delivered to the cell surface receptor
CD14. LPS is then transferred to the transmembrane signaling receptor TLR4 and protein MD2.
Other intracellular signaling pathways are activated by LPS stimulation including the NF-κB
pathway[14].
As shown in Figure 2A, LPS-treatment led to increased TNF-α secretion by THP-1 cells
from 33.2 pg/mL to 1164.3 pg/mL. The increased secretion of TNF-α induced by LPS was dosedependently reduced by BG-4 pre-treatment. At a concentration of 6.25 ppm, BG-4 significantly
reduced TNF-α secretion by 16.2% and at 50 ppm, BG-4 reduced TNF-α secretion by 50.7%.
Figure 2B shows the effect of LPS and BG-4 treatment on IL-6 secretion by THP-1 macrophages.
LPS treatment led to a significant increase in IL-6 secretion by THP-1 macrophages compared to
untreated cells (13.8 vs 466.5 pg/mL). BG-4 treatment starting at 12.5 ppm dose-dependently
reduced IL-6 secretion induced by LPS in THP-1 macrophages reaching 88.4% reduction at 50
ppm. Previous reports have shown the cancer promoting effects of pro-inflammatory cytokines
TNF-α and IL-6. For instance, analysis of different colonic polyps has shown an increased TNF-α
expression in serrated adenoma and hyperplastic polyps as compared to normal colonic
mucosa [15] while factors that can increase the risk of CRC such as high fat diet have shown to
upregulate TNFα secretion promoting formation of colonic adenoma in vivo [16]. In addition,
chronic ethanol feeding increased gene expression of pro-inflammatory cytokines IL-1α, IL-6

and TNF-α at a precancerous stage in chemically-induced colonic tumorigenesis in mice [17].
Our study indicated that BG-4 pre-treatment for 8 hours reduced TNF-α and IL-6 secretion by
THP-1 macrophages when challenged by LPS.
3.2 Western Blot analysis of p-ERK ½ and p-STAT3
We then analyzed proteins associated with overproduction of pro-inflammatory cytokines.
More specifically, we measured the phosphorylation of extracellular regulated kinase ½ (p-ERK
½) and signal transducer and activator of transcription 3 (pSTAT-3) (Figure 3a). The negative
control shows a very low expression as seen in the Western Blot in Figure 3b. Overall BG-4
expression of p-ERK 1/2 and p-STAT3 but only p-ERK ½ reached statistical significance.
3.3 Intracellular Reactive Oxygen Species
We then tested the capability of BG-4 to reduce production of intracellular reactive
oxygen species in LPS-induced THP-1 macrophages. Intracellular reactive oxygen species was
measured by staining THP-1 macrophages with 2′,7′-dichlorodihydrofluorescein diacetate
(H2DCFDA) which becomes the highly green fluorescent 2′,7′-dichlorofluorescein upon
oxidation. As shown in Figure 4, LPS treatment led to increased green fluorescence by THP-1
cells (Figure 4A, top panel at 4x magnification, scale bar 1000 µm and bottom panel at 20 x
magnification, scale bar at 200 µm) which was validated by a fluorescence spectrophotometry
experiment (Figure 4B). Pre-treatment of BG-4 for 8 hours prior to LPS induction led to a dosedependent green fluorescence indicating the capability of BG-4 to reduce production of
intracellular reactive oxygen species induced by LPS in THP-1 macrophages.

3.4 Analysis of p65 subunit of NF-κB transcription factor
To further explain the anti-inflammatory effect of BG-4 using PMA-differentiated THP-1
macrophages, the expression of nuclear-factor of kappa B (NF-κB) p65 unit was measured using
immunofluorescence microscopy and western blotting of THP-1 nuclear lysates. As shown in
Figure 5A, untreated THP-1 macrophages showed cytoplasmic localization of p65 unit (green).
Upon treatment of 1 µg/mL LPS, strong nuclear staining of p65 unit can be seen indicating
translocation of p65 from the cytoplasm into the nucleus (blue) of THP-1 macrophages. On the
other hand, pre-treatment of THP-1 macrophages with 50 ppm BG-4 for 8 h prior to LPSstimulation led to reduced p65 nuclear staining suggesting inhibition of p65 translocation from
the cytoplasm into the nucleus of the cells. This was further verified by western blotting of the
nuclear fraction of THP-1 macrophages indicating reduced expression of NF-κB p65 subunit in
BG-4 pre-treated THP-1 macrophages prior to LPS stimulation as compared to THP-1
macrophages that were stimulated with LPS alone (Figure 5B). NF-κB is an essential
transcription factor regulating various signaling pathways one of which is the expression of
different genes and proteins involved in inflammation. The canonical NF-κB signaling involves
the heterodimeric protein p50-p65 which is activated upon treatment of LPS. The p50 subunit
helped in DNA binding while the p65 subunit is important in activating the transcriptional
activity of NF-κB [18].Previous reports have shown the association of NF-κB signaling in playing
an essential role in inflammation and innate immunity. For instance, NF-κB is increasingly
recognized as a crucial player in many steps of cancer initiation and progression. During these
latter processes, NF-κB works with multiple other signaling molecules and pathways to mediate
crosstalk by other transcription factors such as STAT3 and p53. These transcription factors

either directly interact with NF-κB subunits or affect NF-κB target genes [19]. Our data showed
the capability of BG-4 to attenuate LPS-induced NF-κB signaling supporting our hypothesis that
BG-4 can have an anti-inflammatory effect against THP-1 macrophages. To further elucidate the
mechanism by which BG-4 can be used as a chemopreventive agent against THP-1 cells,
activation of signal transducer and activator of transcription 3 (STAT3) was measured by
immunofluorescence utilizing antibody specific to phosphorylated form of STAT3. As shown in
Figure 6, untreated THP-1 macrophages have very low expression of p-STAT3 while LPS
treatment led to increased green staining of THP-1 macrophages indicative of increased
activation of STAT3 through phosphorylation. Pre-treatment of THP-1 macrophages with 25 and
50 ppm BG-4 for 8 h prior to LPS treatment reduced the green fluorescence staining showing
the capability of BG-4 to prevent phosphorylation of STAT3. Activation of STAT3 signaling has
been implicated as the central mechanism in the development, progression, and maintenance
of many human tumors. It has also been validated as an anti-cancer target as it is involved in
the critical functions of cell differentiation and immune responses [20].

4. Conclusion
Our data show the capability of BG-4 to reduce LPS-induced inflammation in THP-1
human macrophages by reducing the secretion of pro-inflammatory cytokines IL-6 and TNF-α.
In addition, BG-4 pre-treatment led to reduced nuclear translocation of p65 subunit of NF-κB
and phosphorylation of STAT3. Figure 7 shows the proposed mechanism of action for
preventing inflammation. LPS treatment of THP-1 macrophages leads to phosphorylation of ERK
which activates the translocation of p-65 to the nucleus. This leads to the production of reactive oxygen

species and maturation of pro-inflammatory cytokines that can lead to chronic inflammation. Our

results showed that BG-4 pre-treatment inhibited phosphorylation of extracellular regulated
kinase leading to reduced translocation of p65 to the nucleus and reduction of reactive oxygen
species. This leads to a reduction of pro-inflammatory cytokines IL-6 and TNF-alpha which can
possibly explain the chemopreventive effect of BG-4 against chronic inflammation.

Acknowledgements
The University of Tennessee Chancellor’s Honors Program for an Honors Undergraduate
Research Grant.

References
1.
2.

3.

4.
5.
6.
7.

8.
9.

Joseph B, J.D., Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal
potency. Asian Pacific Journal of Tropical Disease, 2013. 3(2): p. 93-102.
Yung, M.M., et al., Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and
Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling
Cascade. Integr Cancer Ther, 2016. 15(3): p. 376-89.
Fan, X., et al., Alpha-MMC and MAP30, two ribosome-inactivating proteins extracted from
Momordica charantia, induce cell cycle arrest and apoptosis in A549 human lung carcinoma
cells. Mol Med Rep, 2015. 11(5): p. 3553-8.
Dia, V.P. and H.B. Krishnan, BG-4, a novel anticancer peptide from bitter gourd (Momordica
charantia), promotes apoptosis in human colon cancer cells. Sci Rep, 2016. 6: p. 33532.
Wang, J., et al., Suppressive effects on cell proliferation and motility in gastric cancer SGC-7901
cells by introducing ulinastatin in vitro. Anticancer Drugs, 2016. 27(7): p. 651-9.
Song, B., et al., Ulinastatin reduces the resistance of liver cancer cells to epirubicin by inhibiting
autophagy. PLoS One, 2015. 10(3): p. e0120694.
Dia, V.P., et al., Bowman-Birk and Kunitz protease inhibitors among antinutrients and bioactives
modified by germination and hydrolysis in Brazilian soybean cultivar BRS 133. J Agric Food Chem,
2012. 60(32): p. 7886-94.
Oparin, P.B., et al., Buckwheat trypsin inhibitor with helical hairpin structure belongs to a new
family of plant defence peptides. Biochem J, 2012. 446(1): p. 69-77.
Wati, R.K., et al., Trypsin inhibitor from 3 legume seeds: fractionation and proteolytic inhibition
study. J Food Sci, 2010. 75(3): p. C223-8.

10.

11.
12.

13.
14.
15.
16.
17.

18.
19.
20.

Sakamoto, H., et al., Biomechanical strain induces class a scavenger receptor expression in
human monocyte/macrophages and THP-1 cells: a potential mechanism of increased
atherosclerosis in hypertension. Circulation, 2001. 104(1): p. 109-14.
Sharif, O., et al., Transcriptional profiling of the LPS induced NF-kappaB response in
macrophages. BMC Immunol, 2007. 8: p. 1.
Chanput, W., et al., Transcription profiles of LPS-stimulated THP-1 monocytes and macrophages:
a tool to study inflammation modulating effects of food-derived compounds. Food Funct, 2010.
1(3): p. 254-61.
Furundzija, V., et al., IGF-1 increases macrophage motility via PKC/p38-dependent alphavbeta3integrin inside-out signaling. Biochem Biophys Res Commun, 2010. 394(3): p. 786-91.
Guha, M. and N. Mackman, LPS induction of gene expression in human monocytes. Cell Signal,
2001. 13(2): p. 85-94.
Szylberg, L., et al., Expression of COX-2, IL-1beta, TNF-alpha and IL-4 in epithelium of serrated
adenoma, adenoma and hyperplastic polyp. Arch Med Sci, 2016. 12(1): p. 172-8.
Zhu, Q.C., et al., Effect of a high-fat diet in development of colonic adenoma in an animal model.
World J Gastroenterol, 2014. 20(25): p. 8119-29.
Shukla, P.K., et al., Chronic ethanol feeding promotes azoxymethane and dextran sulfate sodiuminduced colonic tumorigenesis potentially by enhancing mucosal inflammation. BMC Cancer,
2016. 16: p. 189.
Oeckinghaus, A. and S. Ghosh, The NF-kappaB family of transcription factors and its regulation.
Cold Spring Harb Perspect Biol, 2009. 1(4): p. a000034.
Hoesel, B. and J.A. Schmid, The complexity of NF-kappaB signaling in inflammation and cancer.
Mol Cancer, 2013. 12: p. 86.
Johnston, P.A. and J.R. Grandis, STAT3 signaling: anticancer strategies and challenges. Mol
Interv, 2011. 11(1): p. 18-26.

Figure 1. Electrophoresis profile and trypsin inhibitory activity of aqueous and ethanolic extracts from
Momordica charantia. A) SDS-PAGE profile of different Momordica charantia extracts indicates that increasing
ethanol concentrations (0 to 70% in 10% increment, lanes 1 to 8) in the extraction medium led to isolation and
purification of a novel peptide termed BG-4. B) Trypsin inhibitory activity of Momordica charantia extracts is
associated with the degree of BG-4 purity. Increasing BG-4 purity led to increased capability of the extract to
inhibit trypsin, the purified BG-4 peptide from 70% ethanol extraction (lane 8) is 8.6 times more effective in
inhibiting trypsin

A)

B)

Figure 2. BG-4 pre-treatment reduced the secretion of pro-inflammatory cytokines TNF-α and IL-6 in LPSinduced THP-1 macrophages. A) BG-4 dose dependently reduced TNF-α secretion in LPS-induced THP-1
macrophages, 50 ppm BG-4 reduced TNF-α secretion by 50.7%. B) BG-4 starting at 12.5 ppm dosedependently reduced IL-6 secretion in LPS-induced THP-1 macrophages, 50 ppm BG-4 reduced IL-6 secretion
by 88.4%. Bars with different letter are significantly different from each other (P < 0.05, n > 8).
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Figure 3 Negative control shows very low expression as seen in the Western Blot
-Overall BG-4 significantly blocked the expression of p-ERK but not p-STAT3

A)

B)

Figure 4. BG-4 pre-treatment reduced intracellular
reactive oxygen species production in LPS-induced THP-1
macrophages. A) Images of THP-1 cells stained with
H2DCFDA. Upper panel shows THP-1 cells at 4x
magnification (scale bar is 1000 µm) while lower panel
shows THP-1 cells at 20x magnification (scale bar is 200
µm). The green fluorescence indicates the degree of
intracellular reactive oxygen generation and as shown BG-4
dose-dependently reduce green fluorescence. B) The
reduction in green fluorescence was validated by
quantitative fluorescence spectrophotometry experiment
indicating that BG-4 starting at 6.25 ppm dosedependently reduce intracellular reactive oxygen. Bars
with different letter are significantly different from each
other (P < 0.05, n > 5).
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Figure 5. BG-4 pre-treatment reduced the expression of NF-κB
p65 subunit in the nucleus of PMA-differentiated THP-1
macrophages. A) Immunofluorescence staining of p65 in THP-1
macrophages.

Figure 6. BG-4 pre-treatment reduced activation of signal transducer and activator of transcription 3 (STAT3)
Immunofluorescence experiments were performed in two independent replicates and 6 random fields were
photographed for each replicate (scale bar is 100 µm).

Figure 7. Proposed mechanism of action of inflammation prevention by BG-4.

